Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Dec 14, 2018 9:53am

101 Views

Post# 29115255

RE:RE:RE:Looking for Information

2for1split wrote: So it's not GBM tumor that my family member has, so not quite what they are looking for. He will still try and maintain contact with the company. The frustrating part is I believe Therelase's treatment could save many lives and here we sit stuck in the bureaucratic mush.

Just imagine if treatment was available in a place that was off shore, like The Cayman Islands. People that basically are going to die would have a chance to try this treatment. Sad.

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023